🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/12/2018 14,13 14,16 13,36 13,73 -1,65% 5,70% 1.329.000
17/12/2018 14,20 14,68 13,81 13,96 -2,51% 6,13% 1.456.800
14/12/2018 14,69 15,06 14,25 14,32 -3,24% 5,48% 1.272.300
13/12/2018 15,19 15,47 14,36 14,80 -2,57% 7,31% 1.815.800
12/12/2018 13,50 15,35 13,33 15,19 +11,53% 14,94% 2.976.200
11/12/2018 13,85 14,00 13,58 13,62 -0,29% 3,05% 1.079.000
10/12/2018 13,16 13,80 12,89 13,66 +4,04% 6,91% 1.233.000
07/12/2018 13,52 13,82 13,11 13,13 -3,67% 5,25% 2.106.300
06/12/2018 13,03 13,73 13,01 13,63 +0,74% 5,53% 1.561.100
04/12/2018 14,90 15,18 13,48 13,53 -10,34% 11,41% 1.757.500
03/12/2018 15,02 15,13 14,40 15,09 +3,93% 4,86% 1.409.900
30/11/2018 14,50 14,83 14,30 14,52 -0,62% 3,63% 1.083.300
29/11/2018 14,64 14,98 14,14 14,61 -1,28% 5,74% 1.024.100
28/11/2018 13,50 14,86 13,47 14,80 +10,28% 10,30% 1.520.500
27/11/2018 13,40 13,87 13,22 13,42 -0,59% 4,84% 970.500
26/11/2018 13,20 13,52 13,01 13,50 +3,85% 3,86% 1.234.200
23/11/2018 12,76 13,38 12,41 13,00 +0,39% 7,64% 561.100
21/11/2018 12,56 13,10 12,42 12,95 +5,28% 5,41% 1.040.400
20/11/2018 11,73 12,73 11,55 12,30 +0,74% 10,06% 1.755.100
19/11/2018 13,32 13,55 12,16 12,21 -8,81% 10,44% 2.023.100
16/11/2018 12,89 13,54 12,80 13,39 +3,16% 5,74% 1.666.900
15/11/2018 11,89 13,16 11,83 12,98 +7,63% 11,19% 2.011.300
14/11/2018 12,62 12,83 11,84 12,06 -3,29% 7,84% 1.653.700
13/11/2018 12,94 13,28 12,35 12,47 -2,81% 7,22% 1.576.200
12/11/2018 14,49 14,49 12,81 12,83 -11,46% 11,59% 1.769.200
09/11/2018 15,22 15,29 13,75 14,49 -5,60% 10,11% 2.037.500
08/11/2018 16,09 16,09 14,94 15,35 -4,12% 7,15% 1.806.300
07/11/2018 15,00 16,07 14,94 16,01 +8,25% 7,53% 2.838.900
06/11/2018 14,40 14,97 14,32 14,79 +2,14% 4,51% 1.629.700
05/11/2018 14,60 14,85 14,17 14,48 -0,07% 4,66% 1.573.100